AbbVie Beats Q1 Earnings On Strong Humira Sales, Raises Full-Year Profit Forecast 2021-04-30T13:17:48-04:00April 30th, 2021| share this article! AbbVie Inc (NYSE: ABBV) beat Wall Street consensus for first-quarter revenue & earnings and raised its full-year profit forecast, helped by demand for its… Read More share this article! Related Posts James Comer Slams Marjorie Taylor Greene’s Motion To Oust Mike Johnson: ‘Not The Right Business Model’ April 20th, 2024 Volkswagen workers vote to unionize in major win for organised labour April 20th, 2024 NY AG Letitia James Seeks To Void Trump’s $175M Bond In Civil Fraud Case April 20th, 2024 Medals And Cash: What To Know About Olympian Prize Money For Paris Olympics April 19th, 2024
